$CEOS PsyKey will continue to develop additional s

$CEOS PsyKey will continue to develop additional strategic partnerships as it positions itself in the fast-evolving mushroom markets. With the psychedelic drug market projected to reach the multi-billion-dollar mark by 2027, working with a world-class mycologist and partnering with innovative companies like Zealous, whose goal is commercial production, PsyKey is building on its objectives of long-term growth and increased investor value.